More about

Remission

News
May 05, 2022
2 min read
Save

‘Large proportion’ of patients with PsA fail to meet treatment targets

‘Large proportion’ of patients with PsA fail to meet treatment targets

A “large proportion” of patients with psoriatic arthritis fail to reach treatment targets despite medication, with residual musculoskeletal and skin disease frequently observed, according to data published in Rheumatology and Therapy.

News
April 19, 2022
2 min read
Save

The goal of therapy in RA: LDA vs. remission, or perhaps the patient’s well-being

The goal of therapy in RA: LDA vs. remission, or perhaps the patient’s well-being

This month, we are so lucky to have such an extraordinary panel of experts in the field of rheumatoid arthritis — Daniel Aletaha, MD, MSc; Stanley Cohen, MD; Bryant R. England, MD, PhD; Roy Fleischmann, MD; and Liana Fraenkel, MD, MPH — debate the merits of remission vs. low disease activity as the desired target in the therapy of rheumatoid arthritis.

News
April 19, 2022
13 min read
Save

All or something: Experts debate LDA vs. remission as a target in rheumatoid arthritis

All or something: Experts debate LDA vs. remission as a target in rheumatoid arthritis

Treating to target has, since the dawn of targeted biologic and non-biologic disease modifying anti-rheumatic drugs, permeated every aspect of rheumatology care.

News
March 28, 2022
2 min read
Save

Dupilumab induces eosinophilic esophagitis remission among children with atopic conditions

Dupilumab induces eosinophilic esophagitis remission among children with atopic conditions

Dupilumab effectively induced remission of esophageal disease among children with eosinophilic esophagitis treated with the agent for atopic conditions, according to a study published in Annals of Allergy, Asthma & Immunology.

News
March 24, 2022
1 min read
Save

MRI-derived, noninvasive tissue biomarker aids autoimmune hepatitis patient management

An MRI-derived, noninvasive tissue biomarker improved autoimmune hepatitis management by distinguishing patients in biochemical remission as well as those at risk for relapse, according to a study published in eClinicalMedicine.

News
March 23, 2022
5 min watch
Save

VIDEO: New data show Stelara safe, induces long-term remission in UC

VIDEO: New data show Stelara safe, induces long-term remission in UC

In a Healio video exclusive, Jan Wehkamp, MD, global strategy leader for gastroenterology at Janssen Pharmaceuticals, reports key data points from the company’s 3-year, phase 3 UNIFI study.

News
February 15, 2022
1 min read
Save

US woman is third person to achieve sustained HIV remission after stem cell transplant

US woman is third person to achieve sustained HIV remission after stem cell transplant

A woman from the United States is the third person to achieve sustained treatment-free HIV remission after undergoing a stem cell transplant, researchers announced.

News
February 10, 2022
3 min read
Save

Children can achieve clinical remission of peanut allergy with oral immunotherapy

Children can achieve clinical remission of peanut allergy with oral immunotherapy

Oral immunotherapy with or without probiotic adjuvants conferred sustained unresponsiveness to peanut among allergic children, according to a randomized phase 2b study published in The Lancet Child & Adolescent Health.

News
February 08, 2022
2 min read
Save

Patients with high psychosocial burden less likely to achieve sustained RA remission

Patients with high psychosocial burden less likely to achieve sustained RA remission

Mental health and psychosocial well-being are associated with achieving sustained rheumatoid arthritis remission and treatment response, according to data published in Arthritis Care & Research.

News
January 21, 2022
2 min read
Save

IBD therapies ‘still plateauing’ despite progress: Combining drugs may help break ceiling

IBD therapies ‘still plateauing’ despite progress: Combining drugs may help break ceiling

Despite the considerable progress made in the care of inflammatory bowel disease, current therapies are “still plateauing” in terms of response and remission, according to the keynote speaker at the Crohn’s and Colitis Congress.

View more